Page last updated: 2024-10-26

dipyrithione and Abnormalities, Drug-Induced

dipyrithione has been researched along with Abnormalities, Drug-Induced in 1 studies

Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.

Research Excerpts

ExcerptRelevanceReference
" In the rat teratology study, the high dosage level, 30 mg/kg, dermally administered on Gestation Days 6 through 15 caused slight maternal toxicity, whereas 10 mg/kg produced none."1.27Reproductive toxicological evaluation of Omadine MDS. ( Johnson, DE; Mitoma, C; Schardein, JL; Wedig, JH, 1984)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Johnson, DE1
Schardein, JL1
Mitoma, C1
Wedig, JH1

Other Studies

1 other study available for dipyrithione and Abnormalities, Drug-Induced

ArticleYear
Reproductive toxicological evaluation of Omadine MDS.
    Fundamental and applied toxicology : official journal of the Society of Toxicology, 1984, Volume: 4, Issue:1

    Topics: Abnormalities, Drug-Induced; Animals; Anti-Infective Agents; Body Weight; Female; Fertility; Male; M

1984